| Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study J Schouten, FW Wit, IG Stolte, NA Kootstra, M van der Valk, SE Geerlings, ... Clinical Infectious Diseases 59 (12), 1787-1797, 2014 | 850 | 2014 |
| Future challenges for clinical care of an ageing population infected with HIV: a modelling study M Smit, K Brinkman, S Geerlings, C Smit, K Thyagarajan, A van Sighem, ... The Lancet infectious diseases 15 (7), 810-818, 2015 | 808 | 2015 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 719 | 2021 |
| Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals A van Sighem, L Gras, P Reiss, K Brinkman, F de Wolf Aids 24 (10), 1527-1535, 2010 | 464 | 2010 |
| Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study N Friis-Møller, R Thiebaut, P Reiss, R Weber, A D'Arminio Monforte, ... European journal of cardiovascular prevention & rehabilitation 17 (5), 491-501, 2010 | 441 | 2010 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 439 | 2021 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 329 | 2021 |
| Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile M van der Valk, JJP Kastelein, RL Murphy, F van Leth, C Katlama, ... Aids 15 (18), 2407-2414, 2001 | 326 | 2001 |
| A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients R Van Leeuwen, C Katlama, RL Murphy, K Squires, J Gatell, A Horban, ... Aids 17 (7), 987-999, 2003 | 266 | 2003 |
| Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial MH van der Ree, JM de Vree, F Stelma, S Willemse, M van der Valk, ... The Lancet 389 (10070), 709-717, 2017 | 247 | 2017 |
| Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real … TM Welzel, J Petersen, K Herzer, P Ferenci, M Gschwantler, ... Gut 65 (11), 1861-1870, 2016 | 239 | 2016 |
| Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection M Van der Valk, EH Gisolf, P Reiss, F Wit, A Japour, GJ Weverling, ... Aids 15 (7), 847-855, 2001 | 231 | 2001 |
| Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe AD Marshall, EB Cunningham, S Nielsen, A Aghemo, H Alho, ... The lancet Gastroenterology & hepatology 3 (2), 125-133, 2018 | 165 | 2018 |
| Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways M van der Valk, PH Bisschop, JA Romijn, MT Ackermans, JMA Lange, ... Aids 15 (16), 2093-2100, 2001 | 154 | 2001 |
| Lamin A/C mutations with lipodystrophy, cardiac abnormalities, and muscular dystrophy AJ Van der Kooi, G Bonne, B Eymard, D Duboc, B Talim, M Van der Valk, ... Neurology 59 (4), 620-623, 2002 | 149 | 2002 |
| HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controls KW Kooij, FWNM Wit, J Schouten, M van der Valk, MH Godfried, IG Stolte, ... Aids 30 (2), 241-250, 2016 | 141 | 2016 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 128 | 2022 |
| Cost-effectiveness analysis of pre-exposure prophylaxis for HIV-1 prevention in the Netherlands: a mathematical modelling study BE Nichols, CAB Boucher, M van der Valk, BJA Rijnders, ... The Lancet Infectious Diseases 16 (12), 1423-1429, 2016 | 125 | 2016 |
| Risk factors for sexual transmission of hepatitis C virus among human immunodeficiency virus-infected men who have sex with men: a case-control study JW Vanhommerig, FAE Lambers, J Schinkel, RB Geskus, JE Arends, ... Open forum infectious diseases 2 (3), ofv115, 2015 | 116 | 2015 |
| Transmission networks of HIV-1 among men having sex with men in the Netherlands D Bezemer, A van Sighem, VV Lukashov, L van der Hoek, N Back, ... Aids 24 (2), 271-282, 2010 | 114 | 2010 |
janke schinkelAcademic Medical Center, Department of MicrobiologyVerified email at amc.uva.nl
